#obesity-drugs

[ follow ]
#weight-loss

Ozempic's Muscle-Loss Problem

The newest weight-loss drugs are powerful appetite suppressants that may cause muscle loss.
Losing muscle can have negative impacts on strength, metabolic function, and overall health.

A Drug Half as Good as Ozempic for One-30th the Price

New obesity drugs like GLP-1 receptor agonists are in the spotlight, but older medications also offer weight loss benefits.
There is a lack of awareness about older obesity drugs that have been effective for years prior to the introduction of newer medications like Ozempic and Wegovy.

Is Ozempic an Obesity Drug, or an Everything Drug?

The weekly shots, such as GLP-1 agonists, used for weight loss can have various health benefits beyond shedding pounds.

Weight-loss drug coverage is up in 2024 at the largest U.S. companies, a survey reveals

More U.S. employers are now covering weight-loss drugs, reflecting growing trends in healthcare benefits.

You Could Take Ozempic and Not Lose Any Weight

Obesity drugs like Wegovy and Zepbound are highly effective for some people but not for everyone.
A significant number of patients do not respond to or cannot tolerate the side effects of these drugs.

Patients Hate Forever' Drugs. Is Wegovy Different?

Nonadherence to prescribed medications is a common issue with significant consequences.
Obesity drugs like Wegovy and Zepbound are showing promise in improving medication adherence.

Ozempic's Muscle-Loss Problem

The newest weight-loss drugs are powerful appetite suppressants that may cause muscle loss.
Losing muscle can have negative impacts on strength, metabolic function, and overall health.

A Drug Half as Good as Ozempic for One-30th the Price

New obesity drugs like GLP-1 receptor agonists are in the spotlight, but older medications also offer weight loss benefits.
There is a lack of awareness about older obesity drugs that have been effective for years prior to the introduction of newer medications like Ozempic and Wegovy.

Is Ozempic an Obesity Drug, or an Everything Drug?

The weekly shots, such as GLP-1 agonists, used for weight loss can have various health benefits beyond shedding pounds.

Weight-loss drug coverage is up in 2024 at the largest U.S. companies, a survey reveals

More U.S. employers are now covering weight-loss drugs, reflecting growing trends in healthcare benefits.

You Could Take Ozempic and Not Lose Any Weight

Obesity drugs like Wegovy and Zepbound are highly effective for some people but not for everyone.
A significant number of patients do not respond to or cannot tolerate the side effects of these drugs.

Patients Hate Forever' Drugs. Is Wegovy Different?

Nonadherence to prescribed medications is a common issue with significant consequences.
Obesity drugs like Wegovy and Zepbound are showing promise in improving medication adherence.
moreweight-loss
#eli-lilly

Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions

Many patients are struggling to find their medications due to ongoing shortages, despite recent claims from drug manufacturers that supplies have improved.

Novo Nordisk's Wegovy sales jump on international rollouts

Wegovy's sales surged 79%, exceeding expectations, offering reassurance to investors amid growing competition in the obesity drug market.

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over

Hims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.

Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions

Many patients are struggling to find their medications due to ongoing shortages, despite recent claims from drug manufacturers that supplies have improved.

Novo Nordisk's Wegovy sales jump on international rollouts

Wegovy's sales surged 79%, exceeding expectations, offering reassurance to investors amid growing competition in the obesity drug market.

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over

Hims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.
moreeli-lilly

You've Lost Weight Taking New Obesity Drugs. What Happens if You Stop?

Patients who lose weight with obesity drugs face challenges and uncertainty on how to maintain their weight loss once they reach their goal.

An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche's market value

Positive results in small trials for obesity drugs led to significant market value gains, driven by the large potential market size.
#healthcare-costs

How to Get Off Ozempic

Obesity drugs may need to be taken indefinitely for weight maintenance, but some doctors are exploring short-term use with transition to cheaper alternatives for long-term maintenance.

Patients Hate Forever' Drugs. Is Wegovy Different?

Obesity drugs like Wegovy and Zepbound show potential in improving medication adherence.

How to Get Off Ozempic

Obesity drugs may need to be taken indefinitely for weight maintenance, but some doctors are exploring short-term use with transition to cheaper alternatives for long-term maintenance.

Patients Hate Forever' Drugs. Is Wegovy Different?

Obesity drugs like Wegovy and Zepbound show potential in improving medication adherence.
morehealthcare-costs

The Ozempic Revolution Is Stuck

Obesity drugs like Wegovy were originally created for different purposes, now being repurposed for heart health.
FDA approval of Wegovy for heart health could open access to more Americans, but drug shortages remain a significant barrier.

Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs

The North Carolina State Health Plan has decided to end coverage for weight loss medications due to rising costs.
Appetite-suppressing drugs have been effective in helping patients lose weight and may prevent heart attacks and strokes, which can lead to high hospital bills.
#demand

FDA finds no immediate link between weight-loss drugs and suicidal thoughts

The FDA found no evidence linking obesity drugs to suicidal thoughts or actions in a preliminary review.
Demand for obesity drugs has surged despite insufficient data about their long-term effects and how they work in certain populations.

What to know as weight-loss drugs get popular in the U.S.

Obesity drugs like Ozempic are in high demand in the US, with the market predicted to exceed $150 billion a year within a decade.
The boom in demand for these drugs raises concerns about long-term health effects and increased healthcare spending.

FDA finds no immediate link between weight-loss drugs and suicidal thoughts

The FDA found no evidence linking obesity drugs to suicidal thoughts or actions in a preliminary review.
Demand for obesity drugs has surged despite insufficient data about their long-term effects and how they work in certain populations.

What to know as weight-loss drugs get popular in the U.S.

Obesity drugs like Ozempic are in high demand in the US, with the market predicted to exceed $150 billion a year within a decade.
The boom in demand for these drugs raises concerns about long-term health effects and increased healthcare spending.
moredemand

What to watch in health care in 2024: Obesity drugs, AI

Obesity drugs and innovative technology were major topics at JPMorgan Chase's health care conference.
Affordability and access to care remain major concerns in the healthcare industry.
#glp-1-agonists

Are You Sure You Want an Ozempic Pill?

Pharmaceutical companies are working on developing obesity drugs in pill form.
The current obesity drugs on the market are mostly injectable, but there is a growing demand for pills.

Weight-loss drugs are forcing changes to grocery store offerings

Food companies are adapting products to cater to the changing appetites of consumers prescribed new obesity and diabetes drugs.

Are You Sure You Want an Ozempic Pill?

Pharmaceutical companies are working on developing obesity drugs in pill form.
The current obesity drugs on the market are mostly injectable, but there is a growing demand for pills.

Weight-loss drugs are forcing changes to grocery store offerings

Food companies are adapting products to cater to the changing appetites of consumers prescribed new obesity and diabetes drugs.
moreglp-1-agonists

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.
A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.
The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy.

Doctors Test the Limits of What Obesity Drugs Can Fix

New obesity drugs like Wegovy can positively impact other health conditions like arthritis and high blood pressure.
[ Load more ]